These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35270010)

  • 21. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas.
    Regazzo D; Mondin A; Scaroni C; Occhi G; Barbot M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel
    Uzilov AV; Cheesman KC; Fink MY; Newman LC; Pandya C; Lalazar Y; Hefti M; Fowkes M; Deikus G; Lau CY; Moe AS; Kinoshita Y; Kasai Y; Zweig M; Gupta A; Starcevic D; Mahajan M; Schadt EE; Post KD; Donovan MJ; Sebra R; Chen R; Geer EB
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001602. PubMed ID: 28487882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
    Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
    Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
    Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
    Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas.
    Andonegui-Elguera S; Silva-Román G; Peña-Martínez E; Taniguchi-Ponciano K; Vela-Patiño S; Remba-Shapiro I; Gómez-Apo E; Espinosa-de-Los-Monteros AL; Portocarrero-Ortiz LA; Guinto G; Moreno-Jimenez S; Chavez-Macias L; Saucedo R; Basurto-Acevedo L; Lopez-Felix B; Gonzalez-Torres C; Gaytan-Cervantes J; Ayala-Sumuano JT; Burak-Leipuner A; Marrero-Rodríguez D; Mercado M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.
    Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
    Endocrine; 2017 Mar; 55(3):853-860. PubMed ID: 27220856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
    He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
    Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.
    Iino K; Oki Y; Matsushita F; Yamashita M; Hayashi C; Miura K; Nishizawa S; Nakamura H
    Pituitary; 2007; 10(1):35-45. PubMed ID: 17410413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The experimental study of miRNA in pituitary adenomas.
    Liang S; Chen L; Huang H; Zhi D
    Turk Neurosurg; 2013; 23(6):721-7. PubMed ID: 24310454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
    Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M
    Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
    Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
    Roncaroli F; Faustini-Fustini M; Mauri F; Asioli S; Frank G
    Endocr Pathol; 2002; 13(3):245-9. PubMed ID: 12446925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of silent corticotroph adenomas.
    Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
    Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma.
    Krokker L; Nyírő G; Reiniger L; Darvasi O; Szücs N; Czirják S; Tóth M; Igaz P; Patócs A; Butz H
    Neurochem Res; 2019 Oct; 44(10):2360-2371. PubMed ID: 30945144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I--immunohistochemical study.
    Ohta S; Nishizawa S; Oki Y; Yokoyama T; Namba H
    Pituitary; 2002; 5(4):221-3. PubMed ID: 14558669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACTH adenomas transforming their clinical expression: report of 5 cases.
    Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
    Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.